Metacognitive Therapy for Comorbid Insomnia

Metacognitive Therapy for Patients With a Psychiatric Disorder and Comorbid Insomnia.

The purpose of this study is to determine the effect of meta-cognitive therapy for insomnia.

This study is a randomized controlled trial with 50 patients with a psychiatric disorder and insomnia. The patients will be randomized into two groups of 25 patients. The first group receives meta-cognitive therapy, whereas the second group will be assigned to a waiting list control.

Inclusion Criteria:

• Insomnia secondary to a primary psychiatric disorder

Exclusion Criteria:

• substance abuse, psychotic symptoms, suicidal intentions, severe organic disorder or psychiatric disorder where sleep restriction is not advised, organic sleep disorder.